FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to medicine, particularly to ophthalmology. An ophthalmic composition for treating keratoconjunctival damages and inflammations consists of an aqueous solution containing arabinogalactan 1 to 10 wt %, one or more preserving agents specified in a group consisting of sodium merthiolate, thimerosal, phenylmercuric nitrate or phenylmercuric acetate, phenylethyl alcohol, methyl-, ethyl-, propyl parabene, chlorhexidine acetate or gluconate or chlorobutanol, and containing no benzalkonium chloride. The ophthalmic composition is applied as a lacrimal substitute recommended for people wearing contact lenses.
EFFECT: group of inventions provides treating corneal erosions caused by wearing contact lenses.
16 cl, 5 tbl, 7 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| OPHTHALMIC COMPOSITIONS CONTAINING MUCOADHESIVE POLYSACCHARIDES ABLE TO PROMOTE CORNEAL RE-EPITHELISATION | 2013 |
|
RU2663449C2 |
| OPHTHALMIC COMPOSITIONS OF TAMARIND SEED POLYSACCHARIDE AND HYALURONIC ACID | 2008 |
|
RU2493855C2 |
| GEL-LIKE ARTIFICIAL TEARS WITH ANTISEPTIC AND REPARATIVE ACTION | 2018 |
|
RU2679319C1 |
| OPHTHALMIC COMPOSITION CONTAINING CYCLOSPORINE AND TREHALOSE | 2015 |
|
RU2700927C2 |
| CONTACT LENS CARE SOLUTION | 2020 |
|
RU2755298C1 |
| OPHTHALMOLOGICAL COMPOSITIONS | 2017 |
|
RU2756758C2 |
| EYE DROPS FOR TREATING DRY EYE SYNDROME | 2006 |
|
RU2302231C1 |
| EYE DROPS | 2010 |
|
RU2431470C1 |
| OPHTHALMOLOGIC GEL AND METHOD OF ITS PREPARATION | 2007 |
|
RU2340327C1 |
| PYRROLIDONE-CARBOXYLIC ACID (PCA) FOR OPHTHALMIC USE | 2016 |
|
RU2720993C2 |
